Janux Therapeutics, Inc. (JANX)
14.06
-0.10
(-0.71%)
USD |
NASDAQ |
Mar 20, 16:00
14.06
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics EPS Diluted (Quarterly) : -0.514 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 0.5326 |
| EyePoint Plc | -0.8143 |
| Madrigal Pharmaceuticals, Inc. | -2.566 |
| CorMedix, Inc. | 0.1493 |
| Viking Therapeutics, Inc. | -1.383 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.95M |
| Total Expenses (Quarterly) | 31.95M |
| Enterprise Value | -89.13M |
| Earnings Yield | -13.04% |
| Normalized Earnings Yield | -13.04 |